Australia markets open in 4 hours 25 minutes

AgeX Therapeutics Inc (0X4.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
0.43800.0000 (0.00%)
As of 09:26AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
53
142
34
144
361
Cost of revenue
13
40
13
19
26
Gross profit
40
102
21
125
335
Operating expenses
Research development
1,193
734
1,025
1,456
3,714
Selling general and administrative
5,907
9,328
5,971
6,708
6,721
Total operating expenses
7,100
10,062
6,996
8,164
10,435
Operating income or loss
-7,060
-9,960
-6,975
-8,039
-10,100
Interest expense
2,652
4,900
3,335
1,097
404
Total other income/expenses net
-208
49
-212
554
105
Income before tax
-9,920
-14,811
-10,522
-8,582
-10,399
Income tax expense
-
-
-
0
-150
Income from continuing operations
-9,920
-14,811
-10,522
-8,582
-10,249
Net income
-9,917
-14,803
-10,462
-8,675
-10,865
Net income available to common shareholders
-9,917
-14,803
-10,462
-8,675
-10,865
Basic EPS
-0.38
-
-341.15
-8.09
-10.20
Diluted EPS
-0.38
-
-341.15
-8.09
-10.20
Basic average shares
37,950
-
30.679
1,077
1,071
Diluted average shares
37,950
-
30.679
1,077
1,071